IPO Guru
Bajaj
Listed SME

Modern Diagnostic & Research Centre IPO Subscription Status

Modern Diagnostic & Research Centre IPO was subscribed 350.49 times when bidding closed on 2 Jan 2026: QIB 193.51x, NII 519.38x, Retail 342.46x.

The Modern Diagnostic & Research Centre IPO has been subscribed 350.49x times overall. Retail investors have shown interest with bids for 342.46x the shares available. The Non-Institutional Investor (NII) category has been subscribed 519.38x. Qualified Institutional Buyers (QIBs) have subscribed 193.51x. Data last updated on 25 Aug, 12:56 PM.

The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 31 Dec, 2025 and closes on 02 Jan, 2026. The shares are expected to list on stock exchanges on 07 Jan, 2026.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Live bidding

Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.

Last updated 25 Aug 2026, 12:56 PM
Category Bid details Times
QIB 15,14,00,000 of 7,82,400 193.51x
NII 41,13,45,600 of 7,92,000 519.38x
Retail 46,68,44,800 of 13,63,200 342.46x
TOTAL 1,02,95,90,400 350.49x
Advertisement

Application-wise breakup (estimated)

Approximate application counts — the exchanges don't publish these during bidding. Estimated from shares bid using the typical application size seen in recent IPOs' Basis of Allotment data. Max Applications is the number of allotment slots: one lot per retail winner, and the minimum NII application (the smallest lot count above ₹2 lakh) per sHNI and bHNI winner. Final counts appear here once the Basis of Allotment is out.

Category Est. Applied Times
Retail max 852 1,44,398 169.48x
TOTAL (EST.) 1,44,398

Modern Diagnostic & Research Centre IPO allotment probability

Your odds of an allotment in each category at the current subscription.

Retail (up to ₹2 L)
1 out of 342
~0.3% chance per PAN — based on 342.46x subscription. Winners get exactly 1 lot (₹1.4 L) by SEBI lottery, however many lots you bid.
NII / HNI (above ₹2 L)
1 out of 519
~0.2% chance — lottery allots the minimum application per winner (SEBI NII rule since 2022).
QIB (institutions)
193.51x
Proportionate allotment — at 193.51x, institutions receive ~0.5% of their bid. No lottery; not open to individual investors. Strong institutional endorsement.

Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.

Subscription insights

What the current book is saying, read off the category numbers above.

Retail Allotment

High demand detected. The retail category is heavily oversubscribed, making the allotment a lottery where only 1 out of every 343 applicants will be successful.

Institutional Backing

Massive institutional interest with QIBs subscribing 193.51x. This often signals long-term confidence from professional funds.

Day-wise subscription history

End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.

Date Total
02 Jan 2026
Day 3
376.90x ▼
QIB193.51x NII702.08x Retail342.46x
01 Jan 2026
Day 2
30.87x ▼
QIB8.94x NII53.22x Retail33.85x
31 Dec 2025
Day 1
5.60x ▼
QIB4.01x NII7.96x Retail5.51x

Modern Diagnostic & Research Centre SME IPO dates

From the bidding window to listing. Today is 17 November.

Key dates Listed
  1. Open 31 Dec 2025
  2. Close 02 Jan 2026
  3. Allotment 05 Jan 2026
  4. Refund/credit 06 Jan 2026
  5. Listing 07 Jan 2026

What does this subscription data mean?

IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:

  • 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
  • 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
  • 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
  • 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.

Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.

Frequently asked

What is the current subscription status of Modern Diagnostic & Research Centre IPO?

As of IPO close date (02 Jan, 2026), the Modern Diagnostic & Research Centre IPO is subscribed 350.49x times. Retail category is 342.46x, and NII is 519.38x subscribed.

When is the allotment date for Modern Diagnostic & Research Centre IPO?

The allotment for Modern Diagnostic & Research Centre IPO is expected to be finalized on 05 January, 2026.

What is the GMP of Modern Diagnostic & Research Centre?

The Grey Market Premium (GMP) for Modern Diagnostic & Research Centre is currently ₹14, indicating a potential listing gain of 16%.

When will Modern Diagnostic & Research Centre IPO list on the stock market?

Modern Diagnostic & Research Centre is scheduled to list on BSE and NSE on 07 January, 2026.

What are the chances of getting allotment in Modern Diagnostic & Research Centre IPO?

The retail category is oversubscribed at 342.46x, meaning allotment is by lottery. Statistically, approximately 1 in 343 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.

What does QIB subscription of 193.51x mean for Modern Diagnostic & Research Centre IPO?

Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 193.51x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.

How to check Modern Diagnostic & Research Centre IPO allotment status?

After the allotment date (05 Jan, 2026), you can check your Modern Diagnostic & Research Centre IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.

Explore Modern Diagnostic & Research Centre SME IPO further

Track every stage of this IPO, from subscription to listing.

IPO Guru App
IPO Guru on Android

Subscription moves by the hour. Get it on your phone.

Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.

Get it on Google Play Join the WhatsApp channel

Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.

Total
350.49x
QIB
193.51x
NII
519.38x
Retail
342.46x
Full IPO details
Advertisement